{"id":"https://openalex.org/W14556444","doi":null,"title":"Effect of sildenafil on anxiety in the plus-maze test in mice.","display_name":"Effect of sildenafil on anxiety in the plus-maze test in mice.","publication_year":2004,"publication_date":"2004-05-01","ids":{"openalex":"https://openalex.org/W14556444","mag":"14556444","pmid":"https://pubmed.ncbi.nlm.nih.gov/15215566"},"language":"en","primary_location":{"id":"pmid:15215566","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15215566","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polish journal of pharmacology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109502937","display_name":"Mehmet Kurt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I227306068","display_name":"Ondokuz May\u0131s University","ror":"https://ror.org/028k5qw24","country_code":"TR","type":"education","lineage":["https://openalex.org/I227306068"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Mehmet Kurt","raw_affiliation_strings":["Department of Pharmacology, University of Ondokuz Mayis, Samsun, 55139, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Ondokuz Mayis, Samsun, 55139, Turkey","institution_ids":["https://openalex.org/I227306068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112327769","display_name":"S\u0131rr\u0131 S. Bilge","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sirri S Bilge","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055055159","display_name":"Elif Aks\u00f6z","orcid":"https://orcid.org/0000-0002-4827-804X","observed_orcids":["https://orcid.org/0000-0002-4827-804X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elif Aksoz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047974631","display_name":"Osman Kukula","orcid":"https://orcid.org/0000-0001-5503-2462","observed_orcids":["https://orcid.org/0000-0001-5503-2462"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Osman Kukula","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Suleyman Celik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suleyman Celik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5067040967","display_name":"Y\u00fcksel Kesim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuksel Kesim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2688,"has_fulltext":false,"cited_by_count":78,"citation_normalized_percentile":{"value":0.75012312,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"56","issue":"3","first_page":"353","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.8008000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.8008000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.1363999992609024,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.03280000016093254,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sildenafil","display_name":"sildenafil","score":1.0},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.8920000195503235},{"id":"https://openalex.org/keywords/plus-maze-test","display_name":"plus-maze test","score":0.8809999823570251},{"id":"https://openalex.org/keywords/phosphodiesterase-5-inhibitors","display_name":"phosphodiesterase-5 inhibitors","score":0.8970000147819519},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.824999988079071},{"id":"https://openalex.org/keywords/cgmp-signaling","display_name":"cGMP signaling","score":0.7440000176429749},{"id":"https://openalex.org/keywords/methylene-blue","display_name":"methylene blue","score":0.8569999933242798},{"id":"https://openalex.org/keywords/l-arginine","display_name":"L-arginine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.9100000262260437},{"id":"https://openalex.org/keywords/anxiogenic-effects","display_name":"anxiogenic effects","score":0.8059999942779541},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C2776768464","wikidata":"https://www.wikidata.org/wiki/Q191521","display_name":"Sildenafil","level":2,"score":0.9704504013061523},{"id":"https://openalex.org/C205044023","wikidata":"https://www.wikidata.org/wiki/Q4778117","display_name":"Anxiogenic","level":4,"score":0.8125755786895752},{"id":"https://openalex.org/C2780994212","wikidata":"https://www.wikidata.org/wiki/Q422511","display_name":"Cyclic guanosine monophosphate","level":3,"score":0.7785218954086304},{"id":"https://openalex.org/C173586616","wikidata":"https://www.wikidata.org/wiki/Q5359685","display_name":"Elevated plus maze","level":3,"score":0.6872549653053284},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.6697440147399902},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.583079993724823},{"id":"https://openalex.org/C74534348","wikidata":"https://www.wikidata.org/wiki/Q410798","display_name":"cGMP-specific phosphodiesterase type 5","level":3,"score":0.5553412437438965},{"id":"https://openalex.org/C62826618","wikidata":"https://www.wikidata.org/wiki/Q424304","display_name":"Phosphodiesterase","level":3,"score":0.5067303776741028},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4944632053375244},{"id":"https://openalex.org/C2776766087","wikidata":"https://www.wikidata.org/wiki/Q418251","display_name":"Phosphodiesterase inhibitor","level":2,"score":0.460946649312973},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.425252765417099},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.413520872592926},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3974020481109619},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3733627200126648},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.3004877269268036},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.22422480583190918},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11397895216941833},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.07169914245605469},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068677","descriptor_name":"Sildenafil Citrate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008751","descriptor_name":"Methylene Blue","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:15215566","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15215566","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polish journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.377.9279","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.377.9279","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://rabbit.if-pan.krakow.pl/pjp/pdf/2004/3_353.pdf","raw_type":"text"},{"id":"mag:14556444","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15215566","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W141379371","https://openalex.org/W1968678384","https://openalex.org/W1969869149","https://openalex.org/W1979111403","https://openalex.org/W1997301544","https://openalex.org/W2006014108","https://openalex.org/W2011671805","https://openalex.org/W2036504111","https://openalex.org/W2041341616","https://openalex.org/W2042399338","https://openalex.org/W2072204309","https://openalex.org/W2072253551","https://openalex.org/W2092953670","https://openalex.org/W2103593548","https://openalex.org/W2128466718","https://openalex.org/W2166389885","https://openalex.org/W2467078436"],"related_works":["https://openalex.org/W7100227772","https://openalex.org/W2255815636","https://openalex.org/W393307699","https://openalex.org/W2053199741","https://openalex.org/W2002690292","https://openalex.org/W2043660833","https://openalex.org/W2017095911","https://openalex.org/W2086798506","https://openalex.org/W3013319860","https://openalex.org/W3035559594"],"abstract_inverted_index":{"Several":[0],"studies":[1],"have":[2],"shown":[3],"a":[4,61,135,155,185],"role":[5,42,194],"of":[6,16,20,34,43,47,63,80,91,106,110,123,137,144,157,163],"nitric":[7,186],"oxide/cyclic":[8],"guanosine":[9],"monophosphate":[10],"signaling":[11],"pathway":[12,188],"in":[13,53,57,73,126,147,195],"the":[14,21,40,54,71,74,103,121,142,161,175],"regulation":[15],"anxiety.":[17],"The":[18,32,89,108],"effects":[19],"phosphodiesterase":[22],"(PDE)":[23],"5":[24],"inhibitors":[25],"on":[26,51,70],"anxiety":[27,52],"are":[28],"not":[29],"fully":[30],"understood.":[31],"aim":[33],"present":[35],"study":[36],"was":[37],"to":[38,130,190],"investigate":[39],"possible":[41],"sildenafil,":[44],"an":[45,86,192],"inhibitor":[46],"cyclic":[48],"GMP-specific":[49],"phosphodiesterase,":[50],"plus-maze":[55,75],"test":[56,76],"mice.":[58],"Sildenafil":[59,153],"at":[60,78,134,154],"dose":[62,136,156],"0.5":[64],"mg/kg":[65,84,139,159],"had":[66],"no":[67],"significant":[68],"effect":[69,105],"behavior":[72],"but":[77],"doses":[79],"1":[81],"and":[82,96,115,160,168],"3":[83,158],"induced":[85],"anxiogenic":[87],"effect.":[88,198],"combination":[90,109,162],"sildenafil":[92,111,169],"(1":[93,99,112,170],"mg/kg,":[94,100,113,118,166,171],"i.p.)":[95,101,114,119,167,172],"methylene":[97],"blue":[98],"abolished":[102],"anxiogenic-like":[104,197],"sildenafil.":[107],"L-arginine":[116,164],"(50":[117,165],"decreased":[120,174],"percentage":[122,143],"time":[124,145],"spent":[125,146],"open":[127,148],"arms":[128,149],"compared":[129],"saline-treated":[131],"group.":[132],"Diazepam":[133],"2":[138],"significantly":[140,173],"increased":[141],"(p":[150,178],"<":[151,179],"0.05).":[152,180],"locomotor":[176],"activity":[177],"These":[181],"results":[182],"suggest":[183],"that":[184],"oxide-cGMP":[187],"seems":[189],"play":[191],"important":[193],"sildenafil-induced":[196]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}